Background Laparoscopic sleeve gastrectomy (LSG) is a main surgical treatment for morbid obesity. This research evaluates its impact on weight loss, obesity-related comorbidities, and gastric pouch volume dynamics. This study aimed to assess the outcomes of LSG in morbidly obese cases, focusing on comorbidity resolution, weight loss, and changes in gastric volume over 1 year. Patients and methods The research involved 30 morbidly obese cases (BMI above 40 kg/m 2 or above 35 kg/m 2 with comorbidities) aged 18–60 years, undergoing LSG at Al-Azhar University Hospital. Gastric volume has been assessed using multislice computed tomography (MSCT) at 1 month and 1 year postsurgery. Weight loss and comorbidity outcomes were monitored during monitoring at 1, 3, 6, and 12 months. Results Cases showed significant weight loss, with a mean percentage of excess weight loss increasing from 15.98% at 1 month to 64.01% at 1 year ( P <0.001). Comorbidities like osteoarthritis, hypertension, diabetes, and obstructive sleep apnea resolved or enhanced in most cases. Gastric pouch volume increased significantly from 82.93±11.45 ml at 1 month to 175.8±23.68 ml at 1 year ( P <0.001). No association has been observed among gastric volume increase and inadequate weight regain or weight loss ( P =0.491). Conclusion LSG effectively promotes weight loss and ameliorates obesity-related comorbidities. Gastric dilation occurs as a normal response but does not hinder weight loss outcomes.
Abdelrahim et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: